Finding better treatments for a rare and aggressive cancer called NUT carcinoma
Overcoming Limitations of BETInhibition in NUT Carcinoma
This study is looking at a rare and tough type of cancer called NUT carcinoma, mainly affecting young people, to find out how certain proteins help it grow, with the goal of discovering new ways to treat it.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10984705 on NIH RePORTER |
What this research studies
This research focuses on NUT carcinoma, a rare and aggressive cancer primarily affecting adolescents and young adults, which currently has no effective treatments. The team aims to understand how certain proteins, specifically BRD4-NUT, drive the growth of this cancer by altering the structure of DNA and gene expression. They will explore new therapeutic targets by identifying other factors that work alongside BRD4-NUT to promote cancer growth. By using advanced techniques like CRISPR and studying the 3D structure of chromatin, the researchers hope to develop more effective treatment strategies for patients with NUT carcinoma.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents and young adults diagnosed with NUT carcinoma.
Not a fit: Patients with other types of cancer or those who do not have NUT carcinoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and better survival rates for patients with NUT carcinoma.
How similar studies have performed: Previous research has shown promise in using BET inhibitors for treating various cancers, but this specific approach to NUT carcinoma is novel.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: French, Christopher a — Brigham and Women's Hospital
- Study coordinator: French, Christopher a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.